discuss

Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…

2 days ago

Nexteer Showcases Motion-by-Wire Innovations & Shares Insights on Software-Defined Vehicles at MOVE America

Steer-by-Wire, Rear-Wheel Steering, Brake-by-Wire, Software & More in Detroit September 24-25 DETROIT, Sept. 24, 2025 /PRNewswire/ -- Nexteer Automotive will showcase…

3 days ago

Huawei Launches Xinghe AI Fabric 2.0, Empowering Enterprises to Create Always-on Data Center Networks with Full Computing Power

SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- At HUAWEI CONNECT 2025's inaugural Data Center Innovation Summit, themed "Leading AI DC Innovation…

1 week ago

Herbalife India Honored with ‘Sustainable Supply Chain Award’ at BIGBOX India 2025

BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- Herbalife India, a premier health and wellness company, community, and platform, proudly announces…

4 weeks ago

Scientists Discuss the Recent CancerVax Breakthrough

The Company's scientific team describes how they successfully disguised cancer cells and tricked immune cells into attacking them and reveals…

1 month ago

Radware Schedules Conference Call for Its Second Quarter 2025 Earnings

TEL AVIV, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a global leader in application security and delivery…

3 months ago

UnitedHealth Group Announces Earnings Release Date

--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the…

4 months ago